(Q44854809)

6 December 2017

title

Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old. (English)

1 reference

6 December 2017

0 references

1 reference

Elizabeth Migoya

1

1 reference

6 December 2017

Gregory L Kearns

2

1 reference

6 December 2017

Alan Hartford

3

1 reference

6 December 2017

Jamie Zhao

4

1 reference

6 December 2017

Janet van Adelsberg

5

1 reference

6 December 2017

Carol A Tozzi

6

1 reference

6 December 2017

Barbara Knorr

7

1 reference

6 December 2017

Paul Deutsch

8

1 reference

6 December 2017

publication date

1 May 2004

1 reference

The Journal of Clinical Pharmacology

6 December 2017

published in

1 reference

6 December 2017

volume

44

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

487-494

1 reference

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Modulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Recognizing early asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Pharmacogenetics and pharmacogenomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Leukotriene E4 and granulocytic infiltration into asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Bronchoalveolar lavage findings suggest two different forms of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Leukotrienes in the blood and urine of children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Childhood- versus adult-onset asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264970

21 January 2018

Identifiers

DOI

10.1177/0091270004264970

1 reference

6 December 2017

1 reference